Lensar Inc (LNSR) Stock Price, Quote & News

Company Profile

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, de...

Industry: Medical Devices

Sector: Healthcare

Phone: 888 536 7271

Website: www.lensar.com

Address:

2800 Discovery Drive, Orlando, United States

DonDuck6 Aug. 13 at 6:46 PM

$LNSR yes5

0 · Reply

PyramidPlayers Aug. 13 at 5:54 PM

Put ticker JUNE onto your squeeze watchlist. JUNE has only 770k shares outstanding and only 480k shares public float. Look at what SDOT / VEEE / DFNS / AKAN did on similar share numbers and tell me your opinion! Has JUNE got a similar move coming? Added a big position, hoping for a short squeeze. $LNSR >

0 · Reply

CMWGlobal Aug. 13 at 5:47 PM

$LNSR

0 · Reply

CMWGlobal Aug. 13 at 5:03 PM

$FGI $LNSR getting primed. Look at that chart! 👀🚨👀

0 · Reply

CMWGlobal Aug. 13 at 4:36 PM

$LNSR 👀

0 · Reply

CMWGlobal Aug. 13 at 4:27 PM

$LNSR

0 · Reply

PennySearch Aug. 13 at 3:33 PM

📈 Top Penny Stock Movers by Relative Volume $HCTI — 22.77x RVOL Move: +62% Volume: 22.6M (994.0K average) Market Cap: $2.3M Day Range: 1.26 – 2.18 52-Week Range: 1.00 – 244.80 $PSQH — 18.23x RVOL Move: +11% Volume: 5.9M (321.8K average) Market Cap: $13.3M Day Range: 3.65 – 5.70 52-Week Range: 2.95 – 42.60 $LNSR — 17.99x RVOL Move: +22% Volume: 1.7M (94.2K average) Market Cap: $95.3M Day Range: 7.43 – 8.28 52-Week Range: 4.95 – 12.96 Momentum and unusual volume are driving attention. Which one are you watching? 👀 Not financial advice.

0 · Reply

DayTrade_4Life Aug. 13 at 3:23 PM

🏆From the Watchlist & Alerts Today 13 Aug26: 💪See Profile to Join Us. $FGI: 5.75 to 12.48 (117%) $DFSC: 2.25 to 3.57 (58%) $LIMN: .14 to .20 (42%) $CURI: 3.50 to 4.31 (23%) $LNSR: 7.10 to 8.28 (16%) SCKT: 1.75 to $2 (14%)

0 · Reply

ajmrtxl Aug. 13 at 3:00 PM

$LNSR 's latest data on SqueezeFinder

0 · Reply

PennySearch Aug. 13 at 2:38 PM

⏱️ One-Hour Volume Alert Update $LNSR near $7.79 • 17.57x RVOL Day Range: $7.43 - $8.28 $GXAI near $1.27 • 17.17x RVOL Day Range: $1.22 - $1.42 $CURI near $4.00 • 15.90x RVOL Day Range: $3.57 - $4.31 Unusual volume does not guarantee direction—it highlights attention. Not financial advice.

0 · Reply

LENSAR Earnings Call Transcript: Q2 2026

Aug 13, 2026, 8:30 AM EDT - 7 hours ago

LENSAR Earnings release: Q2 2026

Aug 13, 2026, 7:00 AM EDT - 8 hours ago

LENSAR® Reports Second Quarter 2026 Results and Provides Business Update

Aug 4, 2026, 11:00 AM EDT - 9 days ago

LENSAR Transcript: AGM 2026

Jun 23, 2026, 8:00 AM EDT - 7 weeks ago

LENSAR Proxy statement: Proxy filing

Jun 23, 2026, 8:00 AM EDT - 7 weeks ago

LENSAR Proxy statement: Proxy filing

May 8, 2026, 8:30 AM EDT - 3 months ago

LENSAR Earnings Call Transcript: Q1 2026

May 8, 2026, 8:30 AM EDT - 3 months ago

LENSAR Earnings release: Q1 2026

May 8, 2026, 8:30 AM EDT - 3 months ago

LENSAR Quarterly report: Q1 2026

May 8, 2026, 7:00 AM EDT - 3 months ago

LENSAR® Reports First Quarter 2026 Results and Provides Business Update

May 8, 2026, 7:00 AM EDT - 3 months ago

LENSAR Slides: Corporate presentation

Apr 30, 2026, 7:00 AM EDT - 3 months ago

LENSAR® to Report First Quarter 2026 Results on May 8, 2026

2026-04-01T12:41:01.000Z - 4 months ago

Lensar upgraded to Buy from Hold at Lake Street

Mar 31, 2026, 8:30 AM EDT - 4 months ago

LENSAR Earnings Call Transcript: Q4 2025

Mar 31, 2026, 8:30 AM EDT - 4 months ago

LENSAR Annual report: Q4 2025

Mar 31, 2026, 8:30 AM EDT - 4 months ago

LENSAR Earnings release: Q4 2025

2026-03-31T10:07:00.000Z - 4 months ago

Lensar reports Q4 EPS (12c) vs. ($1.61) last year

Mar 31, 2026, 6:00 AM EDT - 4 months ago

LENSAR® Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update

2026-03-17T20:17:07.000Z - 5 months ago

Lensar upgraded to Buy from Neutral at BTIG

ALC

2026-03-16T23:45:16.000Z - 5 months ago

Closing Bell Movers: Lensar down 24% on terminated Alcon deal

AP BKKT BW NUAI RYTM

2026-03-16T21:05:13.000Z - 5 months ago

Lensar down 23% following termination of merger agreement with Alcon

ALC

2026-03-16T21:00:45.000Z - 5 months ago

Alcon, Lensar agree to terminate merger agreement

ALC

2026-03-16T21:00:14.000Z - 5 months ago

LENSAR trading resumes

Mar 16, 2026, 4:30 PM EDT - 5 months ago

LENSAR® Announces Termination of Merger Agreement with Alcon Research, LLC

2026-03-16T20:25:10.000Z - 5 months ago

LENSAR trading halted, news pending

Feb 25, 2026, 5:00 PM EST - 6 months ago

LENSAR® Provides Update on Pending Acquisition by Alcon

2025-11-06T12:12:10.000Z - 10 months ago

Lensar reports Q3 EPS (31c) vs. (13c) last year

Nov 6, 2025, 7:00 AM EST - 10 months ago

LENSAR® Reports Third Quarter 2025 Results and Provides Business Update

Nov 6, 2025, 7:00 AM EST - 10 months ago

LENSAR Quarterly report: Q3 2025

Nov 6, 2025, 7:00 AM EST - 10 months ago

LENSAR Earnings release: Q3 2025

Nov 5, 2025, 7:00 AM EST - 10 months ago

LENSAR Proxy statement: Proxy Filing

Nov 5, 2025, 7:00 AM EST - 10 months ago

LENSAR Proxy statement: Proxy Filing

Sep 2, 2025, 4:01 PM EDT - 1 year ago

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2025-08-07T11:43:09.000Z - 1 year ago

Lensar reports Q2 EPS (15c) vs (79c) last year

Aug 7, 2025, 7:00 AM EDT - 1 year ago

LENSAR Reports Second Quarter 2025 Results and Provides Business Update

Aug 7, 2025, 7:00 AM EDT - 1 year ago

LENSAR Quarterly report: Q2 2025

Aug 7, 2025, 7:00 AM EDT - 1 year ago

LENSAR Earnings release: Q2 2025

Jun 25, 2025, 8:00 AM EDT - 1 year ago

LENSAR Proxy statement: Proxy Filing

Jun 3, 2025, 5:23 PM EDT - 1 year ago

LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc. - LNSR

ALC

May 22, 2025, 8:00 AM EDT - 1 year ago

LENSAR Proxy statement: Proxy Filing

May 19, 2025, 8:00 AM EDT - 1 year ago

LENSAR Proxy statement: Proxy Filing

2025-05-08T12:11:07.000Z - 1 year ago

Lensar reports Q1 EPS ($2.32) vs. (19c) last year

May 8, 2025, 7:00 AM EDT - 1 year ago

LENSAR Reports First Quarter 2025 Results and Provides Business Update

May 8, 2025, 7:00 AM EDT - 1 year ago

LENSAR Quarterly report: Q1 2025

May 8, 2025, 7:00 AM EDT - 1 year ago

LENSAR Earnings release: Q1 2025

May 7, 2025, 8:00 AM EDT - 1 year ago

LENSAR Proxy statement: Proxy Filing

2025-03-25T19:32:55.000Z - 1 year ago

Lensar downgraded to Hold from Buy at Lake Street

2025-03-25T19:23:18.000Z - 1 year ago

Lensar downgraded to Neutral from Buy at BTIG

2025-03-24T12:12:05.000Z - 1 year ago

Alcon to acquire Lensar for $430M

ALC

2025-03-24T12:10:56.000Z - 1 year ago

Alcon to acquire Lensar for $14.00 per share in cash

ALC

Mar 24, 2025, 8:00 AM EDT - 1 year ago

LENSAR Proxy statement: Proxy Filing

Mar 24, 2025, 8:00 AM EDT - 1 year ago

LENSAR Proxy statement: Proxy Filing

2025-02-28T13:50:46.000Z - 1 year ago

Lensar price target raised to $16 from $12 at Lake Street

Feb 27, 2025, 8:30 AM EST - 1 year ago

LENSAR Earnings Call Transcript: Q4 2024

Feb 27, 2025, 8:30 AM EST - 1 year ago

LENSAR Annual report: Q4 2024

Feb 27, 2025, 8:30 AM EST - 1 year ago

LENSAR Earnings release: Q4 2024

2025-02-27T12:32:07.000Z - 1 year ago

Lensar sees 2025 revenue growth above 27% from $53.5M in 2024

Feb 27, 2025, 7:00 AM EST - 1 year ago

LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update

Feb 19, 2025, 12:00 PM EST - 1 year ago

LENSAR to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 27, 2025

Nov 26, 2024, 8:00 AM EST - 1 year ago

LENSAR to Participate in the BTIG 4th Annual Ophthalmology Day

Nov 7, 2024, 8:30 AM EST - 1 year ago

LENSAR Earnings Call Transcript: Q3 2024

Nov 7, 2024, 8:30 AM EST - 1 year ago

LENSAR Quarterly report: Q3 2024

Nov 7, 2024, 8:30 AM EST - 1 year ago

LENSAR Earnings release: Q3 2024

Nov 7, 2024, 7:00 AM EST - 1 year ago

LENSAR Reports Third Quarter 2024 Results and Provides Business Update

Oct 31, 2024, 7:00 AM EDT - 1 year ago

LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024

Oct 8, 2024, 8:00 AM EDT - 2 years ago

One Millionth Procedure Completed Using LENSAR's Cataract Laser Systems

Sep 9, 2024, 7:00 AM EDT - 2 years ago

LENSAR Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Sep 4, 2024, 8:00 AM EDT - 2 years ago

LENSAR to Participate in Two Upcoming Investor Conferences

Aug 8, 2024, 8:30 AM EDT - 2 years ago

LENSAR Earnings Call Transcript: Q2 2024

Aug 8, 2024, 8:30 AM EDT - 2 years ago

LENSAR Quarterly report: Q2 2024

Aug 8, 2024, 8:30 AM EDT - 2 years ago

LENSAR Earnings release: Q2 2024

Aug 8, 2024, 7:00 AM EDT - 2 years ago

LENSAR Reports Second Quarter 2024 Results and Provides Business Update

Aug 7, 2024, 7:00 AM EDT - 2 years ago

LENSAR Announces Certification for the ALLY® Adaptive Cataract Treatment System in the European Union

Aug 1, 2024, 7:00 AM EDT - 2 years ago

LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

May 29, 2024, 2:40 PM EDT - 2 years ago

LENSAR Transcript: 2024 Leerink Partners Healthcare Crossroads Conference

May 23, 2024, 8:00 AM EDT - 2 years ago

LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference

May 9, 2024, 8:30 AM EDT - 2 years ago

LENSAR Earnings Call Transcript: Q1 2024

May 9, 2024, 8:30 AM EDT - 2 years ago

LENSAR Quarterly report: Q1 2024

May 9, 2024, 8:30 AM EDT - 2 years ago

LENSAR Earnings release: Q1 2024

May 9, 2024, 7:00 AM EDT - 2 years ago

LENSAR Reports First Quarter 2024 Results and Provides Business Update

May 2, 2024, 8:00 AM EDT - 2 years ago

LENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

Mar 25, 2024, 8:00 AM EDT - 2 years ago

LENSAR Proxy statement: Proxy Filing

Mar 25, 2024, 8:00 AM EDT - 2 years ago

LENSAR Proxy statement: Proxy Filing

Mar 4, 2024, 8:30 AM EST - 2 years ago

LENSAR Earnings Call Transcript: Q4 2023

Mar 4, 2024, 8:30 AM EST - 2 years ago

LENSAR Earnings release: Q4 2023

Mar 4, 2024, 8:30 AM EST - 2 years ago

LENSAR Annual report: Q4 2023

Mar 4, 2024, 7:00 AM EST - 2 years ago

LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update

Feb 26, 2024, 8:00 AM EST - 2 years ago

LENSAR to Report Fourth Quarter and Full Year 2023 Financial Results on Monday, March 4, 2024

Dec 13, 2023, 7:00 AM EST - 2 years ago

LENSAR Slides: Corporate Presentation

Nov 16, 2023, 7:00 AM EST - 2 years ago

LENSAR Slides: Corporate Presentation

Nov 9, 2023, 8:30 AM EST - 3 years ago

LENSAR Earnings Call Transcript: Q3 2023

Nov 9, 2023, 8:30 AM EST - 3 years ago

LENSAR Quarterly report: Q3 2023

Nov 9, 2023, 8:30 AM EST - 3 years ago

LENSAR Earnings release: Q3 2023

Nov 9, 2023, 7:00 AM EST - 3 years ago

LENSAR Reports Third Quarter 2023 Results and Provides Business Update

Nov 2, 2023, 8:03 AM EDT - 3 years ago

LENSAR to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023

Aug 24, 2023, 7:00 AM EDT - 3 years ago

LENSAR Slides: Corporate Presentation

Aug 9, 2023, 8:30 AM EDT - 3 years ago

LENSAR Earnings Call Transcript: Q2 2023

Aug 9, 2023, 8:30 AM EDT - 3 years ago

LENSAR Quarterly report: Q2 2023

Aug 9, 2023, 8:30 AM EDT - 3 years ago

LENSAR Earnings release: Q2 2023

Aug 9, 2023, 7:00 AM EDT - 3 years ago

LENSAR Reports Second Quarter 2023 Results and Provides Business Update

Aug 4, 2023, 8:00 AM EDT - 3 years ago

LENSAR Registration statement: Registration Filing

Aug 2, 2023, 8:00 AM EDT - 3 years ago

LENSAR to Report Second Quarter 2023 Financial Results on Wednesday, August 9, 2023

Jul 24, 2023, 7:00 AM EDT - 3 years ago

LENSAR® Reports Adoption of ALLY® System in Multi-Center Ophthalmology Groups

Jun 26, 2023, 8:00 AM EDT - 3 years ago

LENSAR Registration statement: Registration Filing

Jun 20, 2023, 8:00 AM EDT - 3 years ago

LENSAR Proxy statement: Proxy Filing

Jun 20, 2023, 8:00 AM EDT - 3 years ago

LENSAR Proxy statement: Proxy Filing

Jun 8, 2023, 8:00 AM EDT - 3 years ago

LENSAR Proxy statement: Proxy Filing

May 22, 2023, 7:00 AM EDT - 3 years ago

LENSAR Slides: Corporate Presentation

May 15, 2023, 8:30 AM EDT - 3 years ago

LENSAR Earnings Call Transcript: Q1 2023

May 15, 2023, 8:30 AM EDT - 3 years ago

LENSAR Quarterly report: Q1 2023

May 15, 2023, 7:00 AM EDT - 3 years ago

LENSAR Reports First Quarter 2023 Results and Provides Business Update

May 10, 2023, 8:00 AM EDT - 3 years ago

LENSAR to Report First Quarter 2023 Financial Results on Monday, May 15, 2023

Apr 12, 2023, 8:00 AM EDT - 3 years ago

LENSAR Proxy statement: Proxy Filing

Apr 12, 2023, 8:00 AM EDT - 3 years ago

LENSAR Proxy statement: Proxy Filing

Mar 20, 2023, 8:00 AM EDT - 3 years ago

LENSAR Slides: Corporate Presentation

Mar 16, 2023, 8:30 AM EDT - 3 years ago

LENSAR Earnings Call Transcript: Q4 2022

Mar 16, 2023, 8:30 AM EDT - 3 years ago

LENSAR Earnings release: Q4 2022

Mar 16, 2023, 8:30 AM EDT - 3 years ago

LENSAR Annual report: Q4 2022

Mar 16, 2023, 7:00 AM EDT - 3 years ago

LENSAR Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update

Mar 9, 2023, 8:00 AM EST - 3 years ago

LENSAR to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023

Feb 14, 2023, 7:00 AM EST - 3 years ago

LENSAR Announces Preliminary Fourth Quarter and Full Year 2022 Results

Nov 22, 2022, 8:00 AM EST - 4 years ago

LENSAR to Present at Two Upcoming Investor Conferences

Nov 9, 2022, 8:30 AM EST - 4 years ago

LENSAR Earnings Call Transcript: Q3 2022

Nov 9, 2022, 8:30 AM EST - 4 years ago

LENSAR Quarterly report: Q3 2022

Nov 9, 2022, 7:00 AM EST - 4 years ago

LENSAR Reports Third Quarter 2022 Financial Results and Provides Business Update

Nov 2, 2022, 8:00 AM EDT - 4 years ago

LENSAR to Report Third Quarter 2022 Financial Results on Wednesday, November 9, 2022

Sep 8, 2022, 7:00 AM EDT - 4 years ago

LENSAR Announces Application for Certification of the ALLY™ Adaptive Cataract Treatment System in the EU

Aug 16, 2022, 7:00 AM EDT - 4 years ago

First Patients Treated with LENSAR's® ALLY™ Adaptive Cataract Treatment System

Aug 8, 2022, 8:30 AM EDT - 4 years ago

LENSAR Earnings Call Transcript: Q2 2022

Aug 8, 2022, 8:30 AM EDT - 4 years ago

LENSAR Quarterly report: Q2 2022

Aug 8, 2022, 7:00 AM EDT - 4 years ago

LENSAR Reports Second Quarter 2022 Financial Results and Provides Business Update

Aug 1, 2022, 8:00 AM EDT - 4 years ago

LENSAR to Report Second Quarter 2022 Financial Results on Monday, August 8, 2022

Jun 13, 2022, 7:00 AM EDT - 4 years ago

LENSAR® Receives U.S. FDA Clearance of ALLY™ Adaptive Cataract Treatment System

May 9, 2022, 7:00 AM EDT - 4 years ago

LENSAR Reports First Quarter 2022 Financial Results and Provides Business Update

May 2, 2022, 8:00 AM EDT - 4 years ago

LENSAR to Report First Quarter 2022 Financial Results on Monday, May 9, 2022

Apr 12, 2022, 8:00 AM EDT - 4 years ago

LENSAR Proxy statement: Proxy Filing

Apr 12, 2022, 8:00 AM EDT - 4 years ago

LENSAR Proxy statement: Proxy Filing

Mar 3, 2022, 7:00 AM EST - 4 years ago

LENSAR Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

Mar 3, 2022, 7:00 AM EST - 4 years ago

LENSAR Annual report: Q4 2021

Mar 1, 2022, 7:00 AM EST - 4 years ago

LENSAR Announces U.S. Food and Drug Administration Acceptance of 510(k) Submission for ALLY

DonDuck6 Aug. 13 at 6:46 PM

$LNSR yes5

0 · Reply

PyramidPlayers Aug. 13 at 5:54 PM

0 · Reply

CMWGlobal Aug. 13 at 5:47 PM

$LNSR

0 · Reply

CMWGlobal Aug. 13 at 5:03 PM

$FGI $LNSR getting primed. Look at that chart! 👀🚨👀

0 · Reply

CMWGlobal Aug. 13 at 4:36 PM

$LNSR 👀

0 · Reply

CMWGlobal Aug. 13 at 4:27 PM

$LNSR

0 · Reply

PennySearch Aug. 13 at 3:33 PM

0 · Reply

DayTrade_4Life Aug. 13 at 3:23 PM

0 · Reply

ajmrtxl Aug. 13 at 3:00 PM

$LNSR 's latest data on SqueezeFinder

0 · Reply

PennySearch Aug. 13 at 2:38 PM

0 · Reply

SmartMoneyTradez Aug. 13 at 1:59 PM

$LNSR uptrending

0 · Reply

PennySearch Aug. 13 at 1:38 PM

📊 Today's Highest Relative Volume $GXAI — 28.10x RVOL Move: +47% Volume: 41.9M (1.5M average) Market Cap: $13.2M $LNSR — 14.27x RVOL Move: +21% Volume: 892.4K (62.5K average) Market Cap: $96.4M $HCTI — 11.82x RVOL Move: +6% Volume: 4.2M (354.5K average) Market Cap: $1.5M High relative volume highlights where market attention is concentrated. Which one are you watching? 👀 Not financial advice.

0 · Reply

OpenOutcrier Aug. 13 at 12:44 PM

$LNSR (+17.0% pre) LENSAR (LNSR) swings to Q2 2026 profit as revenue and ALLY usage climb https://ooc.bz/l/111105

0 · Reply

BioGem Aug. 13 at 12:39 PM

$LNSR I am re-entering the stock near $7 after Q2 financials. The numbers are impressive. -Revenue growth solid. -Yet operating expenses are plummeting. -Operating leverage is allowing hockey stick profits from here on. -Balance sheet is turning around with bigger cash generation around the corner. No debt. -Alcon knows this is best in class, no wonder why they wanted to take it over. -Short interest is plummeting, means short know this is going much higher.

0 · Reply